Sumary of How the Pandemic Changed Breast Cancer Care:
- TUESDAY, May 4, 2021 — As the COVID-19 pandemic unfolded, breast cancer experts realized space in operating rooms and hospitals could become scarce..
- That meant rethinking standard care, to provide the best way to treat patients under these suddenly restricted conditions..
- Reverse the order of care given to patients with a type of breast cancer known as estrogen receptor-positive (ER+)..
- Instead of getting medication known as neoadjuvant endocrine therapy (NET) after surgery, as is more common, patients would receive NET first and surgery later, because ORs were so scarce..
- The preliminary findings were presented Sunday at an online meeting of the American Society of Breast Surgeons (ASBrS)..
- Treating cancers in this way was part of an effort by the breast surgeons’ group and other cancer societies to develop treatment guidelines for times when access to operating rooms is limited..
- The patterns found in the registry are what cancer experts discussed early in the pandemic, said Dr. Tari King, chief of breast surgery at Dana-Farber/Brigham and Women’s Cancer Center in Boston, who was not involved in the study..
- “We had good data to support that this would be a reasonable strategy for the majority of patients coming in with ER+ breast cancer, that we could use this as a bridge to surgery without negatively impacting their outcomes,”.
- Anti-estrogen endocrine therapy blocks or decreases the ability of hormones to grow certain types of cancer cells…